MX2017006806A - Extractos titulados de cynara scolymus para uso en el tratamiento del mesotelioma. - Google Patents

Extractos titulados de cynara scolymus para uso en el tratamiento del mesotelioma.

Info

Publication number
MX2017006806A
MX2017006806A MX2017006806A MX2017006806A MX2017006806A MX 2017006806 A MX2017006806 A MX 2017006806A MX 2017006806 A MX2017006806 A MX 2017006806A MX 2017006806 A MX2017006806 A MX 2017006806A MX 2017006806 A MX2017006806 A MX 2017006806A
Authority
MX
Mexico
Prior art keywords
treatment
cynara scolymus
mesothelioma
titled
extracts
Prior art date
Application number
MX2017006806A
Other languages
English (en)
Inventor
Mercati Valentino
Original Assignee
Aboca Spa Societa Agricola
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aboca Spa Societa Agricola filed Critical Aboca Spa Societa Agricola
Publication of MX2017006806A publication Critical patent/MX2017006806A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un extracto titulado de Cynara scolymus, a fracciones tituladas de extracto de Cynara scolymus o mezclas tituladas de dicho extracto con una o más de dichas fracciones tituladas o mezclas de dichas fracciones y a composiciones y kits que las comprenden para la prevención y/o el tratamiento de mesotelioma pleural maligno.
MX2017006806A 2014-11-25 2015-11-24 Extractos titulados de cynara scolymus para uso en el tratamiento del mesotelioma. MX2017006806A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM20140685 2014-11-25
PCT/IB2015/059075 WO2016083993A1 (en) 2014-11-25 2015-11-24 Titled extracts of cynara scolymus for use in the treatment of mesothelioma

Publications (1)

Publication Number Publication Date
MX2017006806A true MX2017006806A (es) 2018-01-18

Family

ID=52273397

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017006807A MX2017006807A (es) 2014-11-25 2015-11-24 Extractos titulados de cynara scolymus y usos de los mismos.
MX2017006806A MX2017006806A (es) 2014-11-25 2015-11-24 Extractos titulados de cynara scolymus para uso en el tratamiento del mesotelioma.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2017006807A MX2017006807A (es) 2014-11-25 2015-11-24 Extractos titulados de cynara scolymus y usos de los mismos.

Country Status (11)

Country Link
US (2) US20170340688A1 (es)
EP (2) EP3223839A1 (es)
JP (2) JP2017535617A (es)
CN (2) CN106999596A (es)
AU (2) AU2015352041B2 (es)
BR (1) BR112017010910A2 (es)
CA (2) CA2967746A1 (es)
EA (2) EA201790920A1 (es)
HK (1) HK1244228A1 (es)
MX (2) MX2017006807A (es)
WO (2) WO2016083993A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107496399B (zh) * 2017-08-21 2020-05-05 四川九章生物科技有限公司 一种具有抗肿瘤药物功效的联合用药物
IT201800005721A1 (it) * 2018-05-25 2019-11-25 Nuove composizioni per il trattamento di leiomiomi uterini
CN112479881B (zh) * 2020-11-18 2022-07-29 湖南朗林生物资源股份有限公司 一种朝鲜蓟提取物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19627376A1 (de) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Verwendung von Artischocken-(Cynara)-Extrakten
DE10138929A1 (de) * 2001-08-08 2003-02-27 Lichtwer Pharma Ag Artischockenblätterextrakte
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
PT103839B (pt) * 2007-09-28 2008-10-23 Ecbio Investigacao E Desenvolv Composições farmacêuticas contendo a enzima ciprosina, uma peptidase aspártica de cynara cardunculus, e a sua inclusão em formulações antitumurais
ITRM20130312A1 (it) * 2013-05-29 2014-11-30 Aboca Spa Societa Agricola Estratto di cynara spp. e suoi usi.

Also Published As

Publication number Publication date
CA2967749A1 (en) 2016-06-02
EA201790915A1 (ru) 2017-11-30
WO2016083992A1 (en) 2016-06-02
CN106999596A (zh) 2017-08-01
EP3223839A1 (en) 2017-10-04
HK1244228A1 (zh) 2018-08-03
US20170340689A1 (en) 2017-11-30
WO2016083993A1 (en) 2016-06-02
AU2015352042A1 (en) 2017-06-01
MX2017006807A (es) 2018-01-18
EA201790920A1 (ru) 2017-09-29
AU2015352042B2 (en) 2018-06-21
AU2015352041B2 (en) 2018-08-23
CA2967746A1 (en) 2016-06-02
JP2018501304A (ja) 2018-01-18
EP3223840A1 (en) 2017-10-04
AU2015352041A1 (en) 2017-06-01
US20170340688A1 (en) 2017-11-30
CN106999525A (zh) 2017-08-01
JP2017535617A (ja) 2017-11-30
BR112017010910A2 (pt) 2018-02-06

Similar Documents

Publication Publication Date Title
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
AU359079S (en) A handle of a blending system
AU2016261707A8 (en) Use of cannabis to treat fibromyalgia, methods and compositions thereof
AU364733S (en) Table
AU359879S (en) Stool
AU359130S (en) Respirator filter
AU358179S (en) Hood
AU360264S (en) Respirator filter cover
AU358149S (en) Hood
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
AU358181S (en) Hood
PH12017501022A1 (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
AU359129S (en) Respirator filter retainer
MX2017000862A (es) Formulacion de factor viii.
AU358187S (en) Modesty panel
PH12016501838A1 (en) Compounds and their methods of use
AU363512S (en) Riser
MX2017006806A (es) Extractos titulados de cynara scolymus para uso en el tratamiento del mesotelioma.
AU361072S (en) Firearm scope height tool
MX2017010526A (es) Mezclas de aceite, procesos para la preparacion de estas y su uso en formulas.
MX2021000508A (es) Extracto de sabadilla seco y fluido.
IN2014DE02625A (es)
AU366834S (en) Zipper stopper
AU358459S (en) Fastening tool